1 - 25 of 45 results for author:"Pietsch T." in Literature citations
Results Customize
› Repeat search in UniProtKB (555)
| Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. von Bueren A.O., Bacolod M.D., Hagel C., Heinimann K., Fedier A., Kordes U., Pietsch T., Koster J., Grotzer M.A., Friedman H.S. et al. Br. J. Cancer 107:1399-1408(2012) · Mapped (3) |
| RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas. von dem Knesebeck A., Felsberg J., Waha A., Hartmann W., Scheffler B., Glas M., Hammes J., Mikeska T., Yan P.S., Endl E. et al. Neoplasia 14:526-534(2012) · Mapped (6) |
| Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas. Muller T., Gessi M., Waha A., Isselstein L.J., Luxen D., Freihoff D., Freihoff J., Becker A., Simon M., Hammes J. et al. Am. J. Pathol. 181:675-683(2012) · Mapped (10) |
| Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation. Peterziel H., Muller J., Danner A., Barbus S., Liu H.K., Radlwimmer B., Pietsch T., Lichter P., Schutz G., Hess J. et al. Neuro-oncology 14:426-439(2012) · Mapped (9) |
| Evolutionary history of frogfishes (Teleostei: Lophiiformes: Antennariidae): a molecular approach. Arnold R.J., Pietsch T.W. Mol. Phylogenet. Evol. 62:117-129(2012) · UniProtKB (87) |
| Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas. Waha A., Felsberg J., Hartmann W., Hammes J., von dem Knesebeck A., Endl E., Pietsch T., Waha A. Int. J. Cancer 131:612-622(2012) · Mapped (2) |
| p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. Gessi M., von Bueren A.O., Rutkowski S., Pietsch T. J. Neurooncol. 106:135-141(2012) · Mapped (32) |
| Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Felsberg J., Thon N., Eigenbrod S., Hentschel B., Sabel M.C., Westphal M., Schackert G., Kreth F.W., Pietsch T., Loffler M. et al. Int. J. Cancer 129:659-670(2011) · Mapped (25) |
| Supratentorial primitive neuroectodermal tumors of the central nervous system in adults: molecular and histopathologic analysis of 12 cases. Gessi M., Setty P., Bisceglia M., zur Muehlen A., Lauriola L., Waha A., Giangaspero F., Pietsch T. Am. J. Surg. Pathol. 35:573-582(2011) · Mapped (46) |
| Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts. Philipova T., Baryawno N., Hartmann W., Pietsch T., Druid H., Johnsen J.I., Ekstrom T.J. Int. J. Oncol. 38:843-849(2011) · Mapped (32) |
| Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C., Hentschel B., Wick W., Capper D., Felsberg J., Simon M., Westphal M., Schackert G., Meyermann R., Pietsch T. et al. Acta Neuropathol. 120:707-718(2010) · Mapped (9) |
| TP53, beta-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes. Gessi M., Zur Muehlen A., Lauriola L., Gardiman M.P., Giangaspero F., Pietsch T. Neuropathol. Appl. Neurobiol. 37:406-413(2011) · Mapped (50) |
| p75(NTR) induces apoptosis in medulloblastoma cells. Kuchler J., Hartmann W., Waha A., Koch A., Endl E., Wurst P., Kindler D., Mikeska T., Waha A., Goodyer C.G. et al. Int. J. Cancer 128:1804-1812(2011) · Mapped (11) |
| Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation. Temme A., Geiger K.D., Wiedemuth R., Conseur K., Pietsch T., Felsberg J., Reifenberger G., Tatsuka M., Hagel C., Westphal M. et al. J. Neuropathol. Exp. Neurol. 69:632-642(2010) · Mapped (3) |
| Evolutionary history of anglerfishes (Teleostei: Lophiiformes): a mitogenomic perspective. Miya M., Pietsch T.W., Orr J.W., Arnold R.J., Satoh T.P., Shedlock A.M., Ho H.C., Shimazaki M., Yabe M., Nishida M. BMC Evol. Biol. 10:58-58(2010) · UniProtKB (423) |
| Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Waha A., Felsberg J., Hartmann W., von dem Knesebeck A., Mikeska T., Joos S., Wolter M., Koch A., Yan P.S., Endl E. et al. Cancer Res. 70:1689-1699(2010) · Mapped (2) |
| Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. von Hoff K., Hartmann W., von Bueren A.O., Gerber N.U., Grotzer M.A., Pietsch T., Rutkowski S. Pediatr Blood Cancer 54:369-376(2010) · Mapped (7) |
| Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Kordes U., Gesk S., Fruhwald M.C., Graf N., Leuschner I., Hasselblatt M., Jeibmann A., Oyen F., Peters O., Pietsch T. et al. Genes Chromosomes Cancer 49:176-181(2010) · Mapped (8) |
| Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Weller M., Felsberg J., Hartmann C., Berger H., Steinbach J.P., Schramm J., Westphal M., Schackert G., Simon M., Tonn J.C. et al. J. Clin. Oncol. 27:5743-5750(2009) · Mapped (12) |
| Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Hartmann W., Kuchler J., Koch A., Friedrichs N., Waha A., Endl E., Czerwitzki J., Metzger D., Steiner S., Wurst P. et al. Clin. Cancer Res. 15:4538-4545(2009) · Mapped (16) |
| Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood. Vladimirova V., Mikeska T., Waha A., Soerensen N., Xu J., Reynolds P.C., Pietsch T. Neoplasia 11:700-711(2009) · Mapped (2) |
| Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes. Sahin A., Vercamer C., Kaminski A., Fuchs T., Florin A., Hahne J.C., Mattot V., Pourtier-Manzanedo A., Pietsch T., Fafeur V. et al. Int. J. Oncol. 34:377-389(2009) · Mapped (3) |
| Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Huang J., Grotzer M.A., Watanabe T., Hewer E., Pietsch T., Rutkowski S., Ohgaki H. Clin. Cancer Res. 14:4053-4058(2008) · Mapped (32) |
| BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. Pfister S., Janzarik W.G., Remke M., Ernst A., Werft W., Becker N., Toedt G., Wittmann A., Kratz C., Olbrich H. et al. J. Clin. Invest. 118:1739-1749(2008) · Mapped (3) |
| Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells. Glassmann A., Molly S., Surchev L., Nazwar T.A., Holst M., Hartmann W., Baader S.L., Oberdick J., Pietsch T., Schilling K. BMC Dev. Biol. 7:111-111(2007) · Mapped (3) |